Søren Gräs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Søren Gräs has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Gunnar Lose
Department of Obstetrics and Gynecology, Herlev Gentofte University Hospital, Herlev, Denmark
5 shared publicationsHanna Jangö
Department of Obstetrics and Gynecology, Herlev Gentofte University Hospital, Herlev, Denmark
3 shared publicationsMarianne Starck
Pelvic Floor Center, Department of Surgery, Skåne University Hospital, Malmö, Sweden
3 shared publicationsNiels Klarskov
Department of Obstetrics and Gynecology, Herlev Gentofte University Hospital, Herlev, Denmark
3 shared publicationsJan Fahrenkrug
Department of Clinical Biochemistry, University of Copenhagen, Bispebjerg Hospital, DK-2400 Denmark
2 shared publicationsChristoffer Hedetoft
Department of Clinical Biochemistry, University of Copenhagen, Bispebjerg Hospital, DK-2400 Copenhagen NV, Denmark
1 shared publication
Latest Publications
- 26 August 2025
- Published by Springer Nature in International Urogynecology Journal
- Vol. 37 (2) , 327-334
Prevalence and Predictors of Anal Incontinence 9–12 Months Postpartum in Primipara with Vacuum-Assisted Deliveries
Introduction and Hypothesis We have examined prospectively a large cohort of primipara with VA deliveries and previously reported that approximately one in five had an anal sphincter injury of which one quarter were clinically unrecognized. In this paper, we examine the development and potential predictors of postpartum anal incontinence (AI) in the cohort. We hypothesized that both clinically recognized and unrecognized anal sphincter injuries would be associated with AI development. Methods The participants were interviewed 9–12 months postpartum using the St. Marks incontinence score (SMIS). The primary outcome was the prevalence of de novo AI development defined as SMIS > 0. Logistic regression analysis was used to calculate the odds ratios for selected variables. Results Of 334 eligible women, 271 (81%) were initially included in the study and 248 of them (92%) completed the interview. The prevalence of de novo AI was 21.8% (95% CI 16.4–28.4). Both clinically recognized and unrecognized anal sphincter injuries increased the odds significantly about threefold. Only 35.2% of the symptomatic women had a sphincter injury, and we identified no predictors in the rest. Conclusions Approximately one in five primipara undergoing a VA delivery developed AI. About one third of them were associated with either a clinically recognized or unrecognized anal sphincter injury. Thus, the combination of the two provides the most clinically relevant distinction between anal sphincter injury dependent and independent predictors of AI development. In the symptomatic women with no sphincter injuries, we found no predictive variables.
- 26 August 2025
- Published by Springer Nature in International Urogynecology Journal
- Vol. 37 (2) , 327-334
Prevalence and Predictors of Anal Incontinence 9–12 Months Postpartum in Primipara with Vacuum-Assisted Deliveries
Introduction and Hypothesis We have examined prospectively a large cohort of primipara with VA deliveries and previously reported that approximately one in five had an anal sphincter injury of which one quarter were clinically unrecognized. In this paper, we examine the development and potential predictors of postpartum anal incontinence (AI) in the cohort. We hypothesized that both clinically recognized and unrecognized anal sphincter injuries would be associated with AI development. Methods The participants were interviewed 9–12 months postpartum using the St. Marks incontinence score (SMIS). The primary outcome was the prevalence of de novo AI development defined as SMIS > 0. Logistic regression analysis was used to calculate the odds ratios for selected variables. Results Of 334 eligible women, 271 (81%) were initially included in the study and 248 of them (92%) completed the interview. The prevalence of de novo AI was 21.8% (95% CI 16.4–28.4). Both clinically recognized and unrecognized anal sphincter injuries increased the odds significantly about threefold. Only 35.2% of the symptomatic women had a sphincter injury, and we identified no predictors in the rest. Conclusions Approximately one in five primipara undergoing a VA delivery developed AI. About one third of them were associated with either a clinically recognized or unrecognized anal sphincter injury. Thus, the combination of the two provides the most clinically relevant distinction between anal sphincter injury dependent and independent predictors of AI development. In the symptomatic women with no sphincter injuries, we found no predictive variables.
- 25 March 2025
- Published by Springer Nature in International Urogynecology Journal
- Vol. 36 (7) , 1447-1455
Prevalence and Predictors of Anal Sphincter Injuries in Primipara with Vacuum-Assisted Deliveries
Introduction and Hypothesis Women undergoing a vacuum-assisted (VA) delivery are at an increased risk of experiencing an obstetric anal sphincter injury (OASI). Studies using three-dimensional—endoanal ultrasound (3D-EAUS) have shown that not all OASIs are recognized immediately postpartum. In primipara with VA deliveries, the presence of and the potential clinical implications of undetected OASIs are undetermined and consequently, we examined prospectively a 1-year cohort of this population. We hypothesized that the total rate of OASIs would be higher than the clinically reported rates and wanted to identify potential associated predictors. Methods The participants were examined 10–14 days postpartum with 3D-EAUS. Two experienced examiners, blinded to the clinical data, rated the results. The primary outcome was the combined rate of clinically recognized OASIs and clinically unrecognized ultrasound anal sphincter injuries. Logistic regression analysis was used to calculate the odds ratios for selected variables. Results Of 334 eligible women, 271 (81%) were included. The total rate of OASIs was 19% (95% CI 14–24; 14% clinically recognized and 5% clinically unrecognized). Prolonged second-stage/maternal exhaustion, occiput posterior presentation, and birthweight ≥ 4000g were significant and independent risk factors, increasing the odds two- to three-fold. The indication fetal distress alone or in combination with others significantly reduced the odds. Conclusions About 1 in 5 primipara undergoing a VA delivery experienced an OASI and about one quarter of them were not recognized clinically. The VA procedure is a modifiable intervention, and the identified risk and protective factors may help clinicians to decide whether it should be performed.
- 25 March 2025
- Published by Springer Nature in International Urogynecology Journal
- Vol. 36 (7) , 1447-1455
Prevalence and Predictors of Anal Sphincter Injuries in Primipara with Vacuum-Assisted Deliveries
Introduction and Hypothesis Women undergoing a vacuum-assisted (VA) delivery are at an increased risk of experiencing an obstetric anal sphincter injury (OASI). Studies using three-dimensional—endoanal ultrasound (3D-EAUS) have shown that not all OASIs are recognized immediately postpartum. In primipara with VA deliveries, the presence of and the potential clinical implications of undetected OASIs are undetermined and consequently, we examined prospectively a 1-year cohort of this population. We hypothesized that the total rate of OASIs would be higher than the clinically reported rates and wanted to identify potential associated predictors. Methods The participants were examined 10–14 days postpartum with 3D-EAUS. Two experienced examiners, blinded to the clinical data, rated the results. The primary outcome was the combined rate of clinically recognized OASIs and clinically unrecognized ultrasound anal sphincter injuries. Logistic regression analysis was used to calculate the odds ratios for selected variables. Results Of 334 eligible women, 271 (81%) were included. The total rate of OASIs was 19% (95% CI 14–24; 14% clinically recognized and 5% clinically unrecognized). Prolonged second-stage/maternal exhaustion, occiput posterior presentation, and birthweight ≥ 4000g were significant and independent risk factors, increasing the odds two- to three-fold. The indication fetal distress alone or in combination with others significantly reduced the odds. Conclusions About 1 in 5 primipara undergoing a VA delivery experienced an OASI and about one quarter of them were not recognized clinically. The VA procedure is a modifiable intervention, and the identified risk and protective factors may help clinicians to decide whether it should be performed.
- 12 August 2024
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 31 (8) , 790-798
The Reliability of 3-Dimensional Endoanal Ultrasonography Early and Late Postpartum
Importance: There is no consensus on how to define obstetric anal sphincter defects detected by 3-dimensional endoanal ultrasonography (3D-EAUS), and the reported rates vary significantly in the postpartum period. Objective: The objective of this study was to establish a diagnostic strategy with a high and clinically relevant interrater reliability both early and late postpartum. Study Design: The study was prospective and observational, and 3D-EAUS was performed 10–14 days and 9–12 months postpartum in an unselected cohort of primiparous women with vacuum-assisted deliveries. Two experienced examiners evaluated the ultrasonographic results, which were divided into the categories intact, inconclusive, small, moderate, and large defects based on Starck scores. Three different diagnostic strategies were validated, and the prevalence- and bias-adjusted kappa (PABAK) values calculated. Results: Of 334 eligible women, 184 (55.1%) completed both examinations. Disagreements involving small defects were predominant and observed in 34 and 39 cases, respectively, at the 2 time points. The highest overall agreement rates (91.3% and 92.4%, respectively) and PABAK values (0.83 and 0.85, respectively) were reached when the disagreements were minimized by dichotomizing the results into Starck scores >4 (designated a significant defect) versus Starck scores 0–4 (all others). Conclusions: The interrater reliability of detecting small anal sphincter defects by 3D-EAUS was low at both time points for the 2 experienced raters. In contrast, the interrater reliability of detecting a significant defect was classified as almost perfect agreement at both time points.
- 12 August 2024
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 31 (8) , 790-798
The Reliability of 3-Dimensional Endoanal Ultrasonography Early and Late Postpartum
Importance: There is no consensus on how to define obstetric anal sphincter defects detected by 3-dimensional endoanal ultrasonography (3D-EAUS), and the reported rates vary significantly in the postpartum period. Objective: The objective of this study was to establish a diagnostic strategy with a high and clinically relevant interrater reliability both early and late postpartum. Study Design: The study was prospective and observational, and 3D-EAUS was performed 10–14 days and 9–12 months postpartum in an unselected cohort of primiparous women with vacuum-assisted deliveries. Two experienced examiners evaluated the ultrasonographic results, which were divided into the categories intact, inconclusive, small, moderate, and large defects based on Starck scores. Three different diagnostic strategies were validated, and the prevalence- and bias-adjusted kappa (PABAK) values calculated. Results: Of 334 eligible women, 184 (55.1%) completed both examinations. Disagreements involving small defects were predominant and observed in 34 and 39 cases, respectively, at the 2 time points. The highest overall agreement rates (91.3% and 92.4%, respectively) and PABAK values (0.83 and 0.85, respectively) were reached when the disagreements were minimized by dichotomizing the results into Starck scores >4 (designated a significant defect) versus Starck scores 0–4 (all others). Conclusions: The interrater reliability of detecting small anal sphincter defects by 3D-EAUS was low at both time points for the 2 experienced raters. In contrast, the interrater reliability of detecting a significant defect was classified as almost perfect agreement at both time points.
- 1 September 2014
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 192 (3) , 850-855
Intraurethral Injection of Autologous Minced Skeletal Muscle: A Simple Surgical Treatment for Stress Urinary Incontinence
Intraurethral injection of in vitro expanded autologous skeletal muscle derived cells is a new regenerative therapy for stress urinary incontinence. We examined the efficacy and safety of a simpler alternative strategy using freshly harvested, minced autologous skeletal muscle tissue with its inherent content of regenerative cells. A total of 20 and 15 women with uncomplicated and complicated stress urinary incontinence, respectively, received intraurethral injections of minced autologous skeletal muscle tissue and were followed for 1 year. Efficacy was assessed by the number of leakages in a 3-day diary and by ICIQ-SF scores. We calculated the rates of cure, defined as zero leaks in 3 days plus an ICIQ-SF score of 5 or less, and improvement, defined as simultaneous decreases in each outcome measure. Significant reductions were observed in each group in the mean number of leakages (p <0.01) and in ICIQ-SF scores (p <0.001). In the uncomplicated group cure and improvement were observed in 25% and 63% of patients, and in the complicated group they were noted in 7% and 57%, respectively. No voiding dysfunction developed and only minor adverse events were noted. Intraurethral injection of minced autologous muscle tissue is a simple surgical procedure that appears safe and moderately effective in women with uncomplicated stress urinary incontinence. It compares well to a more complicated regenerative strategy using in vitro expanded muscle derived cells.
- 1 September 2014
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 192 (3) , 850-855
Intraurethral Injection of Autologous Minced Skeletal Muscle: A Simple Surgical Treatment for Stress Urinary Incontinence
Intraurethral injection of in vitro expanded autologous skeletal muscle derived cells is a new regenerative therapy for stress urinary incontinence. We examined the efficacy and safety of a simpler alternative strategy using freshly harvested, minced autologous skeletal muscle tissue with its inherent content of regenerative cells. A total of 20 and 15 women with uncomplicated and complicated stress urinary incontinence, respectively, received intraurethral injections of minced autologous skeletal muscle tissue and were followed for 1 year. Efficacy was assessed by the number of leakages in a 3-day diary and by ICIQ-SF scores. We calculated the rates of cure, defined as zero leaks in 3 days plus an ICIQ-SF score of 5 or less, and improvement, defined as simultaneous decreases in each outcome measure. Significant reductions were observed in each group in the mean number of leakages (p <0.01) and in ICIQ-SF scores (p <0.001). In the uncomplicated group cure and improvement were observed in 25% and 63% of patients, and in the complicated group they were noted in 7% and 57%, respectively. No voiding dysfunction developed and only minor adverse events were noted. Intraurethral injection of minced autologous muscle tissue is a simple surgical procedure that appears safe and moderately effective in women with uncomplicated stress urinary incontinence. It compares well to a more complicated regenerative strategy using in vitro expanded muscle derived cells.
- Open Access
- 14 August 2013
- Published by Springer Nature in International Urogynecology Journal
- Vol. 24 (10) , 1771
Tissue engineering: creation of an autogenic collagenous neoligament for cure of urinary stress incontinence. Reply to Petros
- 14 August 2013
- Published by Springer Nature in International Urogynecology Journal
- Vol. 24 (10) , 1771
Open AccessTissue engineering: creation of an autogenic collagenous neoligament for cure of urinary stress incontinence. Reply to Petros
- 4 January 2013
- Published by Springer Nature in International Urogynecology Journal
- Vol. 24 (5) , 883
Tissue engineering as a potential alternative or adjunct to surgical reconstruction in treating pelvic organ prolapse: reply to Osman et al.
- 4 January 2013
- Published by Springer Nature in International Urogynecology Journal
- Vol. 24 (5) , 883
Tissue engineering as a potential alternative or adjunct to surgical reconstruction in treating pelvic organ prolapse: reply to Osman et al.
- 1 September 2012
- Published by Springer Nature in International Urogynecology Journal
- Vol. 24 (5) , 741-747
Tissue engineering as a potential alternative or adjunct to surgical reconstruction in treating pelvic organ prolapse
Cell-based tissue engineering strategies could potentially provide attractive alternatives to surgical reconstruction of native tissue or the use of surgical implants in treating pelvic organ prolapse (POP).
- 1 September 2012
- Published by Springer Nature in International Urogynecology Journal
- Vol. 24 (5) , 741-747
Tissue engineering as a potential alternative or adjunct to surgical reconstruction in treating pelvic organ prolapse
Cell-based tissue engineering strategies could potentially provide attractive alternatives to surgical reconstruction of native tissue or the use of surgical implants in treating pelvic organ prolapse (POP).
- 20 June 2011
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 90 (8) , 815-824
The clinical relevance of cell‐based therapy for the treatment of stress urinary incontinence
Stress urinary incontinence is a common disorder affecting the quality of life for millions of women worldwide. Effective surgical procedures involving synthetic permanent meshes exist, but significant short‐ and long‐term complications occur. Cell‐based therapy using autologous stem cells or progenitor cells presents an alternative approach, which aims at repairing the anatomical components of the urethral continence mechanism. In vitro expanded progenitor cells isolated from muscle biopsies have been most intensely investigated, and both preclinical trials and a few clinical trials have provided proof of concept for the idea. An initial enthusiasm caused by positive results from early clinical trials has been dampened by the recognition of scientific irregularities. At the same time, the safety issue for cell‐based therapy has been highlighted by the appearance of new and comprehensive regulatory demands. The influence on the cost effectiveness, the clinical relevance and the future perspectives of the present clinical approach are discussed.
- 20 June 2011
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 90 (8) , 815-824
The clinical relevance of cell‐based therapy for the treatment of stress urinary incontinence
Stress urinary incontinence is a common disorder affecting the quality of life for millions of women worldwide. Effective surgical procedures involving synthetic permanent meshes exist, but significant short‐ and long‐term complications occur. Cell‐based therapy using autologous stem cells or progenitor cells presents an alternative approach, which aims at repairing the anatomical components of the urethral continence mechanism. In vitro expanded progenitor cells isolated from muscle biopsies have been most intensely investigated, and both preclinical trials and a few clinical trials have provided proof of concept for the idea. An initial enthusiasm caused by positive results from early clinical trials has been dampened by the recognition of scientific irregularities. At the same time, the safety issue for cell‐based therapy has been highlighted by the appearance of new and comprehensive regulatory demands. The influence on the cost effectiveness, the clinical relevance and the future perspectives of the present clinical approach are discussed.
- 15 May 2005
- Published by Elsevier in Regulatory Peptides
- Vol. 128 (1) , 69-74
Role of pituitary adenylate cyclase-activating peptide (PACAP) in the cyclic recruitment of immature follicles in the rat ovary
- 15 May 2005
- Published by Elsevier in Regulatory Peptides
- Vol. 128 (1) , 69-74
Role of pituitary adenylate cyclase-activating peptide (PACAP) in the cyclic recruitment of immature follicles in the rat ovary
- Open Access
- 1 July 2000
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 63 (1) , 206-212
Pituitary Adenylate Cyclase-Activating Peptide Stimulates Acute Progesterone Production in Rat Granulosa/Lutein Cells via Two Receptor Subtypes1
Pituitary adenylate cyclase-activating peptide (PACAP) is transiently expressed in ovarian granulosa/lutein cells from eCG/hCG-treated rats, and in v
- 1 July 2000
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 63 (1) , 206-212
Open AccessPituitary Adenylate Cyclase-Activating Peptide Stimulates Acute Progesterone Production in Rat Granulosa/Lutein Cells via Two Receptor Subtypes1
Pituitary adenylate cyclase-activating peptide (PACAP) is transiently expressed in ovarian granulosa/lutein cells from eCG/hCG-treated rats, and in v